Abandoning personalization to get to precision in the pharmacotherapy of depression

Measurement-Based Care Versus Standard Care for Major Depression: A Randomized Controlled Trial With Blind Raters

(2015) Tong Guo et al.   AMERICAN JOURNAL OF PSYCHIATRY

THE AMERICAN SOCIETY OF CLINICAL PSYCHOPHARMACOLOGY SURVEY OF PSYCHOPHARMACOLOGISTS’ PRACTICE PATTERNS FOR THE TREATMENT OF MOOD DISORDERS

(2015) Joseph F. Goldberg et al.   DEPRESSION AND ANXIETY

Treatment patterns in inpatient depression care

(2015) Alessa von Wolff et al.   INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH

Stratifying Risk for Renal Insufficiency Among Lithium-Treated Patients: An Electronic Health Record Study

(2015) Victor M Castro et al.   NEUROPSYCHOPHARMACOLOGY

Predictors of outcome for telephone and face-to-face administered cognitive behavioral therapy for depression

(2015) C. Stiles-Shields et al.   PSYCHOLOGICAL MEDICINE

Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder

(2014) Colm O’Dushlaine et al.   BIOLOGICAL PSYCHIATRY

Patient factors associated with SSRI dose for depression treatment in general practice: a primary care cross sectional study

(2014) Chris F Johnson et al.   BMC Family Practice

An Electronic Health Records Study of Long-Term Weight Gain Following Antidepressant Use

(2014) Sarah R. Blumenthal et al.   JAMA Psychiatry

A Clinical Risk Stratification Tool for Predicting Treatment Resistance in Major Depressive Disorder

(2013) Roy H. Perlis   BIOLOGICAL PSYCHIATRY

Taking part in a pharmacogenetic clinical trial: assessment of trial participants understanding of information disclosed during the informed consent process

(2013) Diana Rose et al.   BMC Medical Ethics

Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants

(2013) J K Hicks et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Cytochrome P450 2D6 Phenoconversion Is Common in Patients Being Treated for Depression

(2013) Sheldon H. Preskorn et al.   JOURNAL OF CLINICAL PSYCHIATRY

Variant GADL1 and Response to Lithium Therapy in Bipolar I Disorder

(2013) Chien-Hsiun Chen et al.   NEW ENGLAND JOURNAL OF MEDICINE

QT interval and antidepressant use: a cross sectional study of electronic health records

(2013) V. M. Castro et al.   BMJ-British Medical Journal

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression

(2013) J Winner et al.   Translational Psychiatry

Antidepressant Response in Patients With Major Depression Exposed to NSAIDs: A Pharmacovigilance Study

(2012) Patience J. Gallagher et al.   AMERICAN JOURNAL OF PSYCHIATRY

Effectiveness of a condensed protocol for disclosing APOE genotype and providing risk education for Alzheimer disease

(2012) J. Scott Roberts et al.   GENETICS IN MEDICINE

Biomarkers predicting treatment outcome in depression: what is clinically significant?

(2012) Rudolf Uher et al.   PHARMACOGENOMICS

Using a pharmacogenomic algorithm to guide the treatment of depression

(2012) D K Hall-Flavin et al.   Translational Psychiatry

Antidepressant drugs and the response in the placebo group: the real problem lies in our understanding of the issue

(2011) Konstantinos N Fountoulakis et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Translating biomarkers to clinical practice

(2011) R H Perlis   MOLECULAR PSYCHIATRY

Using electronic health records to drive discovery in disease genomics

(2011) Isaac S. Kohane   NATURE REVIEWS GENETICS

Using electronic medical records to enable large-scale studies in psychiatry: treatment resistant depression as a model

(2011) R. H. Perlis et al.   PSYCHOLOGICAL MEDICINE

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

(2011) R. Uher et al.   PSYCHOLOGICAL MEDICINE

Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models

(2011) Michael J. Pencina et al.   STATISTICS IN MEDICINE

Association Between Bipolar Spectrum Features and Treatment Outcomes in Outpatients With Major Depressive Disorder

(2010) Roy H. Perlis et al.   ARCHIVES OF GENERAL PSYCHIATRY

How and Why to Screen for CYP2D6 Interindividual Variability in Patients Under Pharmacological Treatments

(2010) Manuela De Gregori et al.   CURRENT DRUG METABOLISM

Cytochrome P450 2D6 Phenotype Predicts Antidepressant Efficacy of Venlafaxine

(2010) Kasia W. Lobello et al.   JOURNAL OF CLINICAL PSYCHIATRY

CYP2C19 variation and citalopram response

(2010) David A. Mrazek et al.   Pharmacogenetics and Genomics

Retrospective age at onset of bipolar disorder and outcome during two-year follow-up: results from the STEP-BD study

(2009) Roy H Perlis et al.   BIPOLAR DISORDERS

When is Pharmacogenetic Testing for Antidepressant Response Ready for the Clinic? A Cost-effectiveness Analysis Based on Data from the STAR*D Study

(2009) Roy H Perlis et al.   NEUROPSYCHOPHARMACOLOGY

Difference in Treatment Outcome in Outpatients With Anxious Versus Nonanxious Depression: A STAR*D Report

(2008) Maurizio Fava et al.   AMERICAN JOURNAL OF PSYCHIATRY

Estimating the Danish Populations' Preferences for Pharmacogenetic Testing Using a Discrete Choice Experiment. The Case of Treating Depression

(2008) Louise Herbild et al.   VALUE IN HEALTH